Press Releases

24 Sep 2025

Novel Nanovaccine halts tumour growth and reduces cancer recurrence

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and National Center for Nanoscience and Technology, the Chinese Academy of Sciences (CAS), have jointly developed an approach to significantly reduce the risk of cancer recurrence and metastasis after surgery, by targeting both bulk cancer cells and the elusive cancer stem cells (CSCs) responsible for relapse.

22 Sep 2025

Engineered gut bacteria improves survival outcomes in colorectal cancer tumours

In a new study that combines synthetic biology with cancer immunotherapy, researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Central South University in China have developed an engineered strain of gut-homing bacteria that stimulates potent antitumour immune responses against colorectal cancer (CRC).

19 Sep 2025

New NUS-MOH study: Singapore’s healthcare sector carbon emissions 18% lower than expected, a milestone in the city-state’s net zero journey

In a milestone for Southeast Asia’s healthcare sector, Singapore’s Ministry of Health (MOH), MOH Holdings Pte Ltd (MOHH), and the Centre for Sustainable Medicine (CoSM) at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have released its first-ever comprehensive national emissions report for Singapore’s healthcare sector, and the first comprehensive study across Asia.

15 Sep 2025

Gestational diabetes linked to elevated risk of cognitive decline in mothers, ADHD and autism in children

Children exposed to gestational diabetes face a 36% increased risk of ADHD and 56% higher risk of autism spectrum disorders compared to children born to mothers without diabetes.

11 Sep 2025

Novel AI-powered eye scan predicts risk of cognitive decline and dementia

Researchers at the NUS Yong Loo Lin School of Medicine have validated a retinal ageing marker capable of predicting cognitive decline and dementia up to five years in advance. This non-invasive screening method could lead to early detection, enabling timely interventions and improving outcomes for patients at risk of dementia.

09 Sep 2025

NUS Co-leads Push to Build First Global Medical AI Foundation Model

A global research consortium of over 100 study groups in more than 65 countries has launched the Global RETFound initiative, a collaborative effort to develop the first globally representative Artificial Intelligence (AI) foundation model in medicine, using 100 million eye images.

22 Aug 2025

NUS Medicine establishes Ellen Siow Professorship in Neurosurgery to advance neuro-oncology research

Today, the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) announced the establishment of the Ellen Siow Professorship in Neurosurgery in a tribute to the life and legacy of Ellen Siow and her family’s enduring commitment to medical research, education, and philanthropy.

18 Aug 2025

First-trimester blood test significantly improves prediction of gestational diabetes

A non-fasting blood test taken in the first trimester may allow earlier detection of gestational diabetes, paving the way for timelier and less invasive screening and earlier interventions.

06 Aug 2025

NUS and Harvard study: Lifestyle Changes Can Cut Cardiovascular Disease Risk by Nearly 90% in Women with Gestational Diabetes History

A landmark study led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and Harvard T.H. Chan School of Public Health found that women with a history of gestational diabetes mellitus (GDM) can slash their risk of future cardiovascular disease (CVD) considerably through sustained healthy lifestyle habits.

04 Aug 2025

Journal of Medical Ethics is world’s leading bioethics journal, according to new rankings

The Journal of Medical Ethics (JME), published by BMJ, has just been ranked the number 1 bioethics journal in the world according to the 2025 Google Scholar Metrics, reaffirming its status as the leading global platform for cutting-edge work in medical and bioethics. The journal is co-led by Associate Professor Brian D Earp, Director of the EARP Lab (Experimental Bioethics, Artificial Intelligence, and Relational Moral Psychology Lab) within the Centre for Biomedical Ethics (CBmE), based at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine). He recently took up the role of Co-Editor-in-Chief alongside Professor Lucy Frith, University of Manchester, and Associate Professor Arianne Shahvisi, Brighton & Sussex Medical School.